Abstract Submission will open in February 2026.
Submission Deadline: April 2, 2026

GENERAL INFORMATION ON ABSTRACT SUBMISSION

• EANO accepts regular, encore or trial in progress abstracts.
• Abstracts containing no results or structure will be rejected.
• Abstracts with the obvious goal of advertising corporate products or services, will be rejected.
• All submitted abstracts will be anonymised and reviewed by an independent review panel coordinated by the Scientific Committee.
• Accepted abstracts will be published on the website of Neuro-Oncology beginning of September 2026.
• There will not be a printed abstract book.
• The embargo for abstracts submitted to EANO 2026 will lift on September X, 2026.

REGISTRATION

At least the presenting author of an abstract is obliged to register and pay the congress registration fee within 2 weeks (but not later than July 7, 2026) after notification on acceptance. In the event of non-fulfillment, the abstract will be withdrawn by the organisers.

SUBMISSION TOPICS

01. Tumour cell biology, heterogeneity and plasticity
02. Microenvironment
03. Imaging
04. Computational neuro-oncology
05. Advanced diagnostics and biomarkers
06. Neurocognition and connectome
07. Neurosurgery, drug delivery and advanced techniques
08. Immunotherapy
09. Radiation
10. Pediatric brain tumors
11. Brain metastasis and leptomeningeal disease
12. Adult glioma
13. Meningioma
14. Rare CNS tumors
15. Palliative and supportive care/QoL
16. Public cancer policies and patient involvement
17. Clinical neuro-oncology
18. Preclinical neuro-oncology

SUPPORT

For support during the submission process and any other questions, please send an email to eano-meetings@eano.eu or call +43 1 405 13 83 25 between 09:00 – 17:00 Central European Time.